1,095 results on '"Engstrøm, Thomas"'
Search Results
102. Cardiovascular Magnetic Resonance for Risk Stratification in Patients With ST-Segment–Elevation Myocardial Infarction: A Novel Tool to Tailor Therapy or Emperor’s New Clothes?
103. CT or invasive coronary angiography in stable chest pain
104. Microcirculatory Function in Nonhypertrophic and Hypertrophic Myocardium in Patients With Aortic Valve Stenosis
105. Bleeding Episodes in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Very Early Versus Standard Care Invasive Examination (from the Very EaRly vs Deferred Invasive Evaluation Using Computerised Tomography [VERDICT] Trial)
106. Complete invasive diagnosis of patients with ischemia with nonobstructive coronary arteries: why it matters
107. Long-Term Outcome After Drug-Eluting Versus Bare-Metal Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction: 5 Years Follow-Up From the Randomized DEDICATION Trial (Drug Elution and Distal Protection in Acute Myocardial Infarction)
108. Association Between Early Q Waves and Reperfusion Success in Patients With ST-Segment–Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: A Cardiac Magnetic Resonance Imaging Study
109. Invasive angiography and revascularization in patients with stable angina following prior coronary artery bypass grafting: Results from the East Denmark heart registry
110. Coronary CT and timing of invasive coronary angiography in patients ≥75 years old with non-ST segment elevation acute coronary syndromes.
111. Scar border zone mass and presence of border zone channels assessed with cardiac magnetic resonance imaging are associated with ventricular arrhythmia in patients with ST-segment elevation myocardial infarction.
112. Long-term risk of new-onset arrhythmia in ST-segment elevation myocardial infarction according to revascularization status.
113. Soluble ST2 in plasma is associated with post-procedural no-or-slow reflow after primary percutaneous coronary intervention in ST-elevation myocardial infarction.
114. Automated assessment of heart chamber volumes and function in patients with previous myocardial infarction using multidetector computed tomography
115. Impact of diabetes on 1‐year clinical outcome in patients undergoing revascularization with the BioFreedom stents or the Orsiro stents from the SORT OUT IX trial
116. Fractional Flow Reserve–Guided PCI as Compared with Coronary Bypass Surgery
117. Usefulness of Preprocedure High-Sensitivity C-Reactive Protein to Predict Death, Recurrent Myocardial Infarction, and Stent Thrombosis According to Stent Type in Patients With ST-Segment Elevation Myocardial Infarction Randomized to Bare Metal or Drug-Eluting Stenting During Primary Percutaneous Coronary Intervention
118. Angiography after Out-of-Hospital Cardiac Arrest without ST-Segment Elevation
119. Comparison of Effect of Ischemic Postconditioning on Cardiovascular Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention With Versus Without Thrombectomy
120. Combined In-silico and Machine Learning Approaches Toward Predicting Arrhythmic Risk in Post-infarction Patients
121. Clopidogrel, prasugrel, and ticagrelor for all-comers with ST-segment elevation myocardial infarction
122. Impella mechanical circulatory support: does it take of the load or create a catastrophe?
123. Importance of Risk Assessment in Timing of Invasive Coronary Evaluation and Treatment of Patients With Non–ST‐Segment–Elevation Acute Coronary Syndrome: Insights From the VERDICT Trial
124. Safety of Selective Intracoronary Hypotheria during Primary Percutaneous Coronary Intervention in Patients with Anterior St-Elevation Myocardial Infarction
125. Diagnostic performance of angiography-based fractional flow reserve by patient and lesion characteristics: FAST-FFR substudy
126. Intracoronary Optical Coherence Tomography: Insights from Clinical Research—What Do We Need to Learn?
127. Angiographic outcome in patients treated with deferred stenting after ST-segment elevation myocardial infarction—results from DANAMI-3-DEFER .
128. Basal hyperaemia is the primary abnormality of perfusion in Takotsubo cardiomyopathy: a quantitative cardiac perfusion positron emission tomography study
129. Glucagon-Like Peptide 1—A Cardiologic Dimension
130. Correlation between coronary computed tomographic angiography and fractional flow reserve
131. Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial
132. ST-Segment resolution and clinical outcome with ischemic postconditioning and comparison to magnetic resonance
133. Selective intracoronary hypothermia in patients with ST-elevation myocardial infarction. Rationale and design of the EURO-ICE trial: Intracoronary hypothermia in STEMI
134. Predictors of 10-Year Stent-Related Adverse Outcomes after Coronary Drug-Eluting Stent Implantation: The Importance of Stent Size
135. Is It Safe to Mobilize Patients Very Early After Transfemoral Coronary Procedures? (SAMOVAR)
136. Outcome In Elderly Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction
137. Initiation of and persistence with P2Y12 inhibitors in patients with myocardial infarction according to revascularization strategy: a nationwide study
138. Diagnostic performance of angiography-based fractional flow reserve by patient and lesion characteristics
139. Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction
140. Feasibility and Safety of Prehospital Administration of Bivalirudin in Patients With ST-Elevation Myocardial Infarction
141. Five-year clinical outcomes of zotarolimus-eluting stents in coronary total occlusions: Five-year outcomes with chronic total occlusions
142. Search and rescue helicopter-assisted transfer of ST-elevation myocardial infarction patients from an island in the Baltic Sea: results from over 100 rescue missions
143. Hypercoagulation Assessed by Thromboelastography is Neither Related to Infarct Size nor to Clinical Outcome After Primary Percutaneous Coronary Intervention
144. Measurements of pericardial adipose tissue using contrast enhanced cardiac multidetector computed tomography—comparison with cardiac magnetic resonance imaging
145. Left Atrial Passive Emptying Function Is Preserved in Patients with Permanent Atrial Fibrillation - A 320-Slice Multidetector Computed Tomography Study
146. Insulin resistance genetic risk score and burden of coronary artery disease in patients referred for coronary angiography
147. Coronary Assessment and Revascularization Before Transcutaneous Aortic Valve Implantation: An Update on Current Knowledge
148. Quantitative Flow Ratio to Predict Nontarget Vessel–Related Events at 5 Years in Patients With ST‐Segment–Elevation Myocardial Infarction Undergoing Angiography‐Guided Revascularization
149. Ischemia From Nonculprit Stenoses Is Not Associated With Reduced Culprit Infarct Size in Patients with ST-Segment–Elevation Myocardial Infarction
150. Selective intracoronary hypothermia in patients with ST-elevation myocardial infarction. Rationale and design of the EURO-ICE trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.